A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp

NCT03285477 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratoses

Interventions

DRUG: Placebo
DRUG: KX2-391 Ointment 1%

Sponsor

Almirall, S.A.

Collaborators

[object Object]